Our top pick for
Building a portfolio
Domtar Corporation is a paper & paper products business based in the US. Domtar Corporation shares (UFS) are listed on the NYSE and all prices are listed in US Dollars. Domtar Corporation employs 6,600 staff and has a trailing 12-month revenue of around 0.00.
|52-week range||$18.66 - $40.34|
|50-day moving average||$37.32|
|200-day moving average||$32.18|
|Wall St. target price||$41.61|
|Dividend yield||$0.455 (1.2%)|
|Earnings per share (TTM)||$0.17|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Domtar Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Domtar Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Domtar Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 100x. In other words, Domtar Corporation shares trade at around 100x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Domtar Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 5.86. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Domtar Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Domtar Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $287 million.
The EBITDA is a measure of a Domtar Corporation's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$3.7 billion|
|Operating margin TTM||1.75%|
|Gross profit TTM||$527 million|
|Return on assets TTM||0.82%|
|Return on equity TTM||-6.26%|
|Market capitalisation||$2 billion|
TTM: trailing 12 months
There are currently 4.5 million Domtar Corporation shares held short by investors – that's known as Domtar Corporation's "short interest". This figure is 146.5% up from 1.8 million last month.
There are a few different ways that this level of interest in shorting Domtar Corporation shares can be evaluated.
Domtar Corporation's "short interest ratio" (SIR) is the quantity of Domtar Corporation shares currently shorted divided by the average quantity of Domtar Corporation shares traded daily (recently around 760412.35194585). Domtar Corporation's SIR currently stands at 5.91. In other words for every 100,000 Domtar Corporation shares traded daily on the market, roughly 5910 shares are currently held short.
However Domtar Corporation's short interest can also be evaluated against the total number of Domtar Corporation shares, or, against the total number of tradable Domtar Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Domtar Corporation's short interest could be expressed as 0.09% of the outstanding shares (for every 100,000 Domtar Corporation shares in existence, roughly 90 shares are currently held short) or 0.1035% of the tradable shares (for every 100,000 tradable Domtar Corporation shares, roughly 104 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Domtar Corporation.
Find out more about how you can short Domtar Corporation stock.
We're not expecting Domtar Corporation to pay a dividend over the next 12 months.
Domtar Corporation's shares were split on a 2:1 basis on 17 June 2014. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Domtar Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Domtar Corporation shares which in turn could have impacted Domtar Corporation's share price.
Over the last 12 months, Domtar Corporation's shares have ranged in value from as little as $18.66 up to $40.34. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Domtar Corporation's is 1.9255. This would suggest that Domtar Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Domtar Corporation designs, manufactures, markets, and distributes communication papers, specialty and packaging papers, and absorbent hygiene products in the United States, Canada, Europe, Asia, and internationally. It operates through two segments, Pulp and Paper, and Personal Care. The company provides business papers, including copy and electronic imaging papers used in inkjet and laser printers, photocopiers, and plain-paper fax machines, as well as computer papers, preprinted forms, and digital papers for office and home use. It also offers commercial printing and publishing papers, such as offset papers and opaques used in sheet and roll fed offset presses; publishing papers, which include tradebook and lightweight uncoated papers for publishing textbooks, dictionaries, catalogs, magazines, hard cover novels, and financial documents; and converting papers for envelopes, tablets, business forms, and data processing/computer forms. In addition, the company provides papers for thermal printing, flexible packaging, food packaging, medical packaging, medical gowns and drapes, sandpaper backing, carbonless printing, labels and other coating, and laminating applications; and papers for industrial and specialty applications, such as carrier papers, treated papers, security papers, and specialized printing and converting applications. Further, it offers absorbent hygiene products, including absorbent briefs, protective underwear, underpads, pads, washcloths, and body patches under the Attends, Indasec, IndasSlip, and Reassure brands; and baby diapers, training and youth pants, and bed mats under the Comfees, Chelino, Nene, and Bambino brand names. The company serves merchants, retail outlets, stationers, printers, publishers, converters, and end-users.
Everything we know about the Krispy Kreme IPO, plus information on how to buy in.
Everything we know about the Day One Biopharmaceuticals IPO, plus information on how to buy in.
Everything we know about the Enact Holdings IPO, plus information on how to buy in.
Everything we know about the Solid Power IPO, plus information on how to buy in.
Everything we know about the Paymentus Holdings IPO, plus information on how to buy in.
Everything we know about the Qiniu Limited IPO, plus information on how to buy in.
Everything we know about the Qiniu Limited IPO, plus information on how to buy in.
Everything we know about the Ximalaya IPO, plus information on how to buy in.
Everything we know about the Zeta Global Holdings Corp IPO, plus information on how to buy in.
Everything we know about the Paycor HCM IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.